You may have heard of Myriad Genetics: They're a biotechnology company that briefly got famous in 2013 when the Supreme Court stepped in to rule that the company's patents on BRCA-1 and BRCA-2, genes associated with a higher risk of breast cancer, didn't actually hold good. The case was an ...